Back to search
Asthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Asthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Asthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis) trials you may qualify forIntroduction: The etiology and therapy of eosinophilic lung diseases are still poorly understood. For individual forms of disease, such as eosinophilic asthma o…
Reslizumab is a type of medicine called a monoclonal antibody that is made in the research clinic; it works by blocking a specific protein in the body called in…
The rationale of the roll-over study (ROSY) is to provide continuous access to study treatment for participants who have completed or exited a parent study and…
As part of a post approval commitment, the MFDS has requested a study to characterize safety in patients who are treated with FASENRA for severe eosinophilic as…
Aim of the study is to identify potential biomarkers, through a proteomic approach, which could be used to evaluate organ damage and predict the response to mep…